Business
Press Release Jun 08 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 08, 2023, titled "Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 08, 2023, titled \"Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg\". View Attachment","length":387,"tagName":"div"}]